Cargando…
Oxidative profiling of the failing right heart in rats with pulmonary hypertension
Right heart failure is the major cause of death among patients with pulmonary arterial hypertension (PAH). Understanding the biology of the right ventricle (RV) should help developing new therapeutic strategies. Rats subjected to the injection of Sugen5416 (an inhibitors of vascular endothelial grow...
Autores principales: | Wang, Xinhong, Shults, Nataliia V., Suzuki, Yuichiro J. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Public Library of Science
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5417519/ https://www.ncbi.nlm.nih.gov/pubmed/28472095 http://dx.doi.org/10.1371/journal.pone.0176887 |
Ejemplares similares
-
Ultrastructural Changes of the Right Ventricular Myocytes in Pulmonary Arterial Hypertension
por: Shults, Nataliia V., et al.
Publicado: (2019) -
Redox Biology of Right-Sided Heart Failure
por: Shults, Nataliia V., et al.
Publicado: (2018) -
Apoptosis-based therapy to treat pulmonary arterial hypertension
por: Suzuki, Yuichiro J., et al.
Publicado: (2016) -
Natural reversal of pulmonary vascular remodeling and right ventricular remodeling in SU5416/hypoxia-treated Sprague-Dawley rats
por: Zungu-Edmondson, Makhosazane, et al.
Publicado: (2017) -
Case Report: Two Case Reports of Pulmonary Hypertension after mRNA COVID-19 Vaccination
por: Sullivan, Robert D., et al.
Publicado: (2023)